Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Samnick

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2026
Molecular imaging of lymphatic organs provides prognostic value after acute myocardial infarctionTheresa Reiter, Anna-Lena Dörrler, Natalie Hasenauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Theranostics|May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaConstantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Brain : a Journal of Neurology|July 5, 2014
Parkinson's disease in GTP cyclohydrolase 1 mutation carriersNiccolò E Mencacci, Ioannis U Isaias, Martin M Reich, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2026
Molecular imaging of lymphatic organs provides prognostic value after acute myocardial infarctionTheresa Reiter, Anna-Lena Dörrler, Natalie Hasenauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2023
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors-a comprehensive analysis of imaging findings and comparison with histopathologyNiklas Dreher, Stefanie Hahner, Carmina T Fuß, et al.
Theranostics|May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaConstantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Cancers|August 28, 2020
The Link between Cytogenetics/Genomics and Imaging Patterns of Relapse and Progression in Patients with Relapsed/Refractory Multiple Myeloma: A Pilot Study Utilizing 18F-FDG PET/CTXiang Zhou, Alexander Dierks, Olivia Kertels, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone LymphomaJohannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2015
First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary DiseaseKen Herrmann, Margret Schottelius, Constantin Lapa, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2022
Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms Using <sup>68</sup>Ga-Pentixafor PETAndreas K Buck, Alexander Haug, Niklas Dreher, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Brain : a Journal of Neurology|July 5, 2014
Parkinson's disease in GTP cyclohydrolase 1 mutation carriersNiccolò E Mencacci, Ioannis U Isaias, Martin M Reich, et al.
Pageof 10